Compared Antileishmanial Activity of Clomiphene and Tamoxifen.
Leishmania
amastigote
clomiphene
mouse
promastigote
tamoxifen
Journal
Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304
Informations de publication
Date de publication:
09 Oct 2024
09 Oct 2024
Historique:
received:
05
08
2024
revised:
20
08
2024
accepted:
03
09
2024
medline:
26
10
2024
pubmed:
26
10
2024
entrez:
26
10
2024
Statut:
epublish
Résumé
Drug repositioning is an efficient strategy to search for new treatment alternatives that is especially valuable for neglected parasitic diseases such as leishmaniasis. Tamoxifen and raloxifene are selective estrogen receptor modulators (SERMs) that have shown antileishmanial activity. Clomiphene is a SERM structurally similar to tamoxifen, whose antileishmanial potential is unknown. That is why the objective of the present work was to evaluate its antileishmanial activity in vitro and in vivo in comparison with tamoxifen. The inhibitory effect against promastigotes of
Identifiants
pubmed: 39457604
pii: biomedicines12102290
doi: 10.3390/biomedicines12102290
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Consejo Nacional de Humanidades, Ciencias y Tecnologías
ID : 284018
Organisme : Wellcome Trust
ID : 212422
Pays : United Kingdom